Evidence map›Paper›PMID 40087482›Full record

ArticleScientific reports2025

Favorable pharmacokinetic and tolerability profiles make carprofen an attractive analgesic for subcutaneous injection and oral self-administration in rats.

Aylina Glasenapp, Jens P Bankstahl, Heike Bähre, Andrey Kozlov, Silke Glage, Marion Bankstahl

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Carprofen and buprenorphine delivery using micropipette-guided drug administration (MDA) in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aylina GlasenappInstitute for Laboratory Animal Science and Central Animal Facility, Hannover Medical School, Hannover, Germany.
Jens P BankstahlDepartment of Nuclear Medicine, Hannover Medical School, Hannover, Germany.
Heike BähreResearch Core Unit Metabolomics, Hannover Medical School, Hannover, Germany.
Andrey KozlovLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA. Austrian Cluster for Tissue Regeneration, Vienna, Austria.
Silke GlageInstitute for Laboratory Animal Science and Central Animal Facility, Hannover Medical School, Hannover, Germany.
Marion BankstahlInstitute for Laboratory Animal Science and Central Animal Facility, Hannover Medical School, Hannover, Germany. bankstahl.marion@mh-hannover.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As basis for evidence-based analgesia refinement, species-specific pharmacokinetic and tolerability profiles of carprofen were determined in rats for least aversive administration routes and prolonged treatment. Further, potential influence on behavioral pain indicators was evaluated. LC-MS/MS determined plasma concentrations in Sprague-Dawley rats (n = 21/sex) after subcutaneous (s.c.) injection (5 mg/kg) and during a 5-day treatment via the drinking water (d.w., 10 mg/kg/24 h). Irwin test parameters, clinical scoring, body weight, body temperature, fluid and food intake, grimace scale, burrowing, nesting, hematology, and histopathology were investigated. Plasma concentrations early after injection were higher in females, reached a maximum (C

Indexed as

AnalgesicsCarbazolesAdministration, OralAnimalsFemaleInjections, SubcutaneousMalePainRatsRats, Sprague-DawleySelf AdministrationAnalgesicsCarbazolescarprofenAnalgesiaCarprofenDrinking waterPharmacokineticsRatsTolerability

Identifiers

PMID40087482
PMCPMC11909198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.